歐洲的電生理學映射及切除裝置市場 是由出版商Millennium Research Group在2011年11月所出版的。
這份英文市場調查報告書價格從美金5995起跳。
歐洲電生理學映射及切除裝置市場在2011年達到3億6000萬美金的規模。該市場由於高齡化及心房顫動治療數量的增加，及改善臨床環境的技術革新等因素，預計到2016年將持續擴大。
本報告提供歐洲的電生理學映射及切除裝置市場相關分析，彙整臨床環境，產品概要，臨床實驗趨勢，品牌概要與競爭趨勢，市場資料分析等，為您概述為以下內容。
摘要整理
第1章 臨床環境
- 適應
- 心房纖維顫動
- 房室結迴旋頻脈
- 沃爾夫-巴金森-懷特氏症候群
- 心房纖維顫動
- 心房心搏過速
- 心室心搏過速
- 診斷和轉診模式
- 治療概要
- 臨床指南
- 回本指南
- 各國概要
- 第2章 產品
- 概要
- 電生理學實驗室系統
- 電生理學診斷導管
- 電生理學導管消融術
第3章 臨床實驗
第4章 品牌及競爭分析
- 概要
- 競爭概要
- 更多的競爭環境
- 市場佔有率
- 近幾年的活動
- 電生理學實驗室系統市場
- 電生理學診斷導管
- 電生理學導管消融術
第5章 市場預測
- 概要
- 電生理學實驗室系統市場
- 電生理學診斷導管
- 電生理學導管消融術
附錄A:調查方法
附錄B:用語
附錄C:參考資訊
圖表
Abstract
The European electrophysiology (EP) mapping and ablation device market -
comprising sales of EP lab systems as well as diagnostic and ablation
catheters in France, Germany, Italy, and the UK - was valued over $360 million
in 2011 and will expand through 2016, driven primarily by rising EP procedure
volumes. Growth will be driven primarily by an aging population, an increase
in atrial fibrillation (AF) treatment volumes, increased physician confidence
and proficiency in performing ablations, and technological innovation allowing
for better clinical outcomes and faster procedure times. Market value will,
however, continue to be limited by the enduring popularity of pharmaceutical
treatments, although European guidelines are anticipated to change to
designate ablation procedures as a first-line treatment option. Moreover,
recent health care budget constraints have led to an increasingly
cost-conscious environment, resulting in the possibility of increased
reprocessing practices in the European countries. Another significant limiter
is the low number of electrophysiologists available to meet demand, a
consequence of a steep learning curve and long training periods. Nevertheless,
growth in the European EP mapping and ablation device market will be strong
through 2016.
METHODOLOGY
RESEARCH METHODOLOGY
This report uses a number of methodologies to gather and present data and
analysis. At the outset, a large survey of secondary sources is conducted.
These sources act as the basis for the primary research stage, which builds
and enhances the quantitative and qualitative attributes of the early research.
Secondary sources include
- Government sources:
- Securities and Exchange Commission filings
- Food and Drug Administration and patent filings
- National Center for Health Statistics data
- U.S. National Institute of Health clinical trials registry
- Electrophysiology (EP) mapping and ablation device companies:
- Annual reports, product brochures, corporate profiles, etc.
- Internal databases and reports:
- Previous reports on similar/related sources
- General Internet searches, medical literature, and newspaper/magazine
searches:
- Identifying various centers of specialization and articles that might
provide leads for primary research
The secondary research stage builds the foundation for the primary research.
The primary research methodology has four steps:
Step 1: The first step involves an impartial scan of all the
information gathered during the secondary research stage to determine its
utility based on the specific requirements of this report. Each piece of
information is either discarded or marked as high- or low-priority and then
organized appropriately as determined by the structure and sectioning of the
report.
Step 2: At this stage, early assumptions are formed as to the
implications of the information for the various EP mapping and ablation device
market segments. These assumptions are then used to determine hypotheses using
both inductive and deductive approaches. On the quantitative front, these
hypotheses result in full historical and projected market data sets (market
sizes - unit sales, average selling prices [ASPs], and revenues - as well as
market shares).
Step 3: At this stage, the research is in position for its most
important primary phase - expert interviews. Throughout the secondary research
phase, industry and medical experts are identified.
These experts are then contacted by telephone and asked to participate in
interviews on recent trends and developments in the industry. Interviews are
either conducted at the time of the initial call or scheduled at the
convenience of the expert. Interview questions are tailored to the expertise
of each particular interviewee, although in most cases, the most important
questions are asked of all experts.
The questions are largely based on the assumptions and hypotheses developed in
Step 2, which are then augmented, discarded, or adjusted based on the views
and positions put forth. Attempts are made, whenever possible, to cross-check
the views of various experts against each other and to reach positions of
consensus on issues and market numbers.
Step 4: The final stage of primary research involves individual and
group analysis by Millennium Research Group. All research results are assessed
and cross-checked thoroughly to determine their validity, relevance, and
weight. From this process, qualitative conclusions are reached and data points
finalized.
MARKETRACK METHODOLOGY
Millennium Research Group's Marketrack methodology involves recruiting
hospital personnel responsible for the management of EP mapping and ablation
device and procedures to participate by providing procedure volumes, device
usage data, and brand-level pricing information on an ongoing basis. Hospital
respondents include facility managers, nurses, administrators, and physicians.
For Millennium Research Group's Europe EP mapping and ablation device
Marketrack project, information is collected from 120 facilities in Europe on
a quarterly basis, including, but not limited to, numbers and types of
procedures performed and devices used.
FORECAST METHODOLOGY
In addition to the research methodology outlined above, the following
“bottom-up” methodology is used to develop forecast assumptions
for the report.
A comprehensive breakdown of various EP mapping and ablation device procedures
and unit sales is prepared using data from several sources, including
professional associations, government statistics, and private research/media
sources. Industry experts and practitioners are consulted to ensure accuracy
and verify observed trends. As a cross-check, total industry revenues
available through annual reports and other sources are compared against
modeled industry revenues.
Using the best estimates of industry experts, practitioners, private
research/media sources, and inhouse experts, year-by-year growth rates and
ASPs are applied individually to each subcategory to derive forecasts. These
estimates are cross-checked by industry experts (marketing managers, product
managers, CEOs, etc.) and further refined.
Overall findings are compared against market and procedure forecasts published
by other sources to ensure reasonable estimates.
Companies mentioned in this report
- Advanced Cardiac Therapeutics
- Biosense Webster
- BIOTRONIK
- Boston Scientific
- CardioFocus
- Catheter Robotics
- C. R. Bard
- ELA Medical
- Endosense
- GE Healthcare
- Hansen Medical
- Imricor Medical Systems
- Magnetecs
- Medtronic
- MRI Interventions
- Osypka Medical
- Philips Healthcare
- Rhythmia Medical
- Siemens Healthcare
- Stereotaxis
- St. Jude Medical
- Topera Medical
- Toshiba Medical Systems
- Voyage Medical
Table of Contents
TABLE OF CONTENTS
LIST OF FIGURES AND TABLES
EXECUTIVE SUMMARY
1.0. CLINICAL LANDSCAPE
- 1.1. Indications
- 1.1.1. Atrial Fibrillation
- 1.1.2. Atrioventricular Nodal Reentry Tachycardia
- 1.1.3. Wolff-Parkinson-White Syndrome
- 1.1.4. Atrial Flutter
- 1.1.5. Atrial Tachycardia
- 1.1.6. Ventricular Tachycardia
- 1.2. Diagnosis and Referral Patterns
- 1.3. Procedure Overview
- 1.3.1. Ablation Catheter Procedures
- 1.3.2. Competing Treatments
- 1.4. Clinical Guidelines
- 1.5. Reimbursement Guidelines
- 1.6. Country Overviews
- 1.6.1. France
- 1.6.1.1. Demographics and Economy
- 1.6.1.2. Health Care System
- 1.6.1.3. Regulatory Environment
- 1.6.2. Germany
- 1.6.2.1. Demographics and Economy
- 1.6.2.2. Health Care System
- 1.6.2.3. Regulatory Environment
- 1.6.3. Italy
- 1.6.3.1. Demographics and Economy
- 1.6.3.2. Health Care System
- 1.6.3.3. Regulatory Environment
- 1.6.4. UK
- 1.6.4.1. Demographics and Economy
- 1.6.4.2. Health Care System
- 1.6.4.3. Regulatory Environment
2.0. PRODUCTS
- 2.1. Overview
- 2.2. Electrophysiology Lab Systems
- 2.2.1. Functions
- 2.2.2. Differentiating Features
- 2.2.3. Labeled Indications
- 2.2.4. Emerging Products
- 2.3. Electrophysiology Diagnostic Catheters
- 2.3.1. Functions
- 2.3.2. Differentiating Features
- 2.3.3. Labeled Indications
- 2.3.4. Emerging Products
- 2.4. Electrophysiology Ablation Catheters
- 2.4.1. Functions
- 2.4.2. Differentiating Features
- 2.4.3. Labeled Indications
- 2.4.4. Emerging Products
3.0. CLINICAL TRIALS
- 3.1. Completed Clinical Trials
- 3.1.1. Device-Specific Trials
- 3.1.2. Procedure-Specific Trials
- 3.2. Ongoing Clinical Trials
- 3.2.1. Device-Specific Trials
- 3.2.2. Procedure-Specific Trials
- 3.2.2.1. Ablation Trials
- 3.2.2.2. Hybrid Procedure Trials
4.0. BRANDS AND COMPETITIVE ANALYSIS
- 4.1. Overview
- 4.1.1. Competitive Snapshot
- 4.1.2. Detailed Competitive Landscape
- 4.1.3. Market Shares
- 4.1.4. Recent Events
- 4.2. Electrophysiology Lab System Market
- 4.2.1. Competitive Snapshot
- 4.2.2. Leading Competitors
- 4.2.3. Current Market Shares
- 4.3. Electrophysiology Diagnostic Catheter Market
- 4.3.1. Competitive Snapshot
- 4.3.2. Leading Competitors
- Current 4.3.3 Market Shares
- 4.4. Electrophysiology Ablation Catheter Market
- 4.4.1. Competitive Snapshot
- 4.4.2. Leading Competitors
- 4.4.3. Current Market Shares
5.0. MARKET OUTLOOK
- 5.1. Overview
- 5.1.1. Market Snapshot
- 5.1.2. Detailed Market Overview
- 5.2. Electrophysiology Lab System Market
- 5.2.1. Market Snapshot
- 5.2.2. Detailed Market Overview
- 5.3. Electrophysiology Diagnostic Catheter Market
- 5.3.1. Market Snapshot
- 5.3.2. Detailed Market Overview
- 5.4. Electrophysiology Ablation Catheter Market
- 5.4.1. Market Snapshot
- 5.4.2. Detailed Market Overview
APPENDIX A: METHODOLOGY
APPENDIX B: MRG ACRONYMS AND INITIALISMS
APPENDIX C: BIBLIOGRAPHY
LIST OF FIGURES AND TABLES
TABLE OF CONTENTS
LIST OF FIGURES AND TABLES
EXECUTIVE SUMMARY
- Figure 1: EP Mapping and Ablation Device Market, by Product Type, Europe
(US$), 2010 - 2016
- Table 1: EP Mapping and Ablation Device Market Landscape, Europe (US$),
2011 and 2016
- Table 2: EP Mapping and Ablation Device Market Leaders, by Product Type
and Revenue, Europe, 2011
- Table 3: Most Promising Emerging Technologies in the EP Mapping and
Ablation Device Market, Europe, 2011 - 2016
- Table 4: Expected Key Events in the EP Mapping and Ablation Device Market,
Europe, 2012 - 2016
- Table 5: Factors Impacting the EP Mapping and Ablation Device Market, by
Product Type, Europe, 2011 - 2016
- Table 6: Companies Mentioned in This Report
- Table 7: Key Report Updates, 2012
1.0 CLINICAL LANDSCAPE
- Table 8: Treatment Providers and Referral Patterns, by Treatment Phase,
Europe
- Figure 2: Treatment Providers and Referral Patterns, Europe
- Table 9: EP Catheter Procedures
- Table 10: Competing Treatments, Europe
- Table 11: Expected Changes to AF Treatment Guidelines, UK
- Table 12: EP Mapping and Ablation Device Reimbursement Guidelines, by
Country, Europe
- Table 13: Key Health and Economic Indicators, France, 2011
- Table 14: Key Health and Economic Indicators, Germany, 2011
- Table 15: Key Health and Economic Indicators, Italy, 2011
- Table 16: Key Health and Economic Indicators, UK, 2011
2.0 PRODUCTS
- Table 17: EP Mapping and Ablation Device Market, by Product Type, Europe
- Table 18: EP Lab System Functions
- Table 19: Typical Lab System Life Span
- Table 20: Advantages and Disadvantages of EP Lab Systems, by Product Type
- Table 21: Emerging Products in Development for the EP Lab System Market,
Europe, 2011 - 2016
- Table 22: Diagnostic Catheter Functions, by Product Type and Product
Feature
- Table 23: Advantages and Disadvantages of Diagnostic Catheters, by Product
Type and Product Feature
- Table 24: Emerging Products in Development for the Diagnostic Catheter
Market, Europe, 2011 - 2016
- Table 25: EP Ablation Catheter Functions
- Table 26: Advantages and Disadvantages of Ablation Catheters, by Product
Type and Product Feature
- Table 27: Advantages and Disadvantages of Irrigated-Tip RF Ablation
Catheters, by Product Feature
- Table 28: Emerging Products in Development for the EP Ablation Catheter
Market, Europe, 2011 - 2016
3.0 CLINICAL TRIALS
- Table 29: Summary of TTOP AF Study
- Table 30: Summary of EZCF-125
- Table 31: Summary of STOP-AF
- Table 32: Summary CABANA Pilot Trial
- Table 33: Summary of APAF 2
- Table 34: Summary of RICTAM
- Table 35: Summary of Clinical Study to Evaluate the Catheter Robotics
Amigo for Performing Right-Sided Electrophysiology Mapping Studies
- Table 36: Summary of EAS-AC
- Table 37: Summary of CLARITY-AF
- Table 38: Summary of BLOCk-CTI
- Table 39: Summary of ARTISAN-AF Study
- Table 40: Summary of the ThermoCool SmartTouch Catheter for the Treatment
of Symptomatic Paroxysmal Atrial Fibrillation Trial
- Table 41: Summary of TOCCASTAR
- Table 42: Summary of RAAFT Study
- Table 43: Summary of DISCERN-AF Study
- Table 44: Summary of FAST II
- Table 45: Summary of ERASE-VT
- Table 46: Summary of MANTRA-PAF Study
- Table 47: Summary of CASTLE-AF Study
- Table 48: Summary of CABANA
- Table 49: Summary of EAST
- Table 50: Summary of DEEP
- Table 51: Summary of Atrial Fibrillation Ablation The Hybrid Approach
Versus Traditional Management Study
4.0 BRANDS AND COMPETITIVE ANALYSIS
- Table 52: Leading Competitors in the EP Mapping and Ablation Device
Market, by Product Type, as a % of Total, Europe, 2011
- Table 53: Recent Events in the EP Mapping and Ablation Device Market,
Europe, 2011
- Table 54: Leading Competitors and Brands in the EP Lab System Market, by
Product Type, Europe, 2011
- Table 55: Leading Competitors in the EP Lab System Market, by Product
Type, as a % of Total, Europe, 2011
- Table 56: Leading Competitors and Brands in the EP Diagnostic Catheter
Market, by Product Feature, Europe, 2011
- Table 57: Leading Competitors in the EP Diagnostic Catheter Market, by
Product Type, as a % of Total, Europe, 2011
- Table 58: Leading Competitors in the Conventional Diagnostic Catheter
Market, by Country, as a % of Total, Europe, 2011
- Table 59: Leading Competitors in the Conventional Fixed Diagnostic
Catheter Market, by Country, as a % of Total, Europe, 2011
- Table 60: Leading Competitors in the Conventional Steerable Diagnostic
Catheter Market, by Country, as a % of Total, Europe, 2011
- Table 61: Leading Competitors in the Advanced Diagnostic Catheter Market,
by Country, as a % of Total, Europe, 2011
- Table 62: Leading Competitors in the Advanced Loop Diagnostic Catheter
Market, by Country, as a % of Total, Europe, 2011
- Table 63: Leading Competitors in the Advanced Other Diagnostic Catheter
Market, by Country, as a % of Total, Europe, 2011
- Table 64: Leading Competitors and Brands in the EP Ablation Catheter
Market, Product Feature, Europe, 2011
- Table 65: Leading Competitors in the EP Ablation Catheter Market, by
Product Feature, as a % of Total, Europe, 2011
- Table 66: Leading Competitors in the RF Conventional Ablation Catheter
Market, by Country, as a % of Total, Europe, 2011
- Table 67: Leading Competitors in the RF Irrigated-Tip Ablation Catheter
Market, by Country, as a % of Total, Europe, 2011
- Table 68: Leading Competitors in the RF Specialty Ablation Catheter
Market, by Country, as a % of Total, Europe, 2011
5.0 MARKET OUTLOOK
- Figure 3: EP Mapping and Ablation Device Market, by Product Type, as a %
of Total, Europe, 2011 and 2016
- Table 69: Factors Impacting the EP Mapping and Ablation Device Market, by
Product Type, Europe, 2011 - 2016
- Table 70: EP Catheter Procedures, by Procedure Type and Country, Europe,
2010 - 2016
- Table 71: EP Catheter Procedure Growth, by Procedure Type and Country,
Europe, 2011 - 2016
- Table 72: EP Mapping and Ablation Device Market, by Country, Europe (US$,
€ , and £), 2010 - 2016
- Table 73: EP Mapping and Ablation Device Market, by Product Type, Europe
(US$ and € ), 2010 - 2016
- Figure 4: EP Lab System Market, by Product Type, Europe (US$), 2010 - 2016
- Table 74: EP Labs, by Country, Europe, 2010 - 2016
- Table 75: EP Lab System Penetration, by Product Type, Europe, 2010 - 2016
- Table 76: X-Ray System Installed Base, by Country, Europe, 2010 - 2016
- Table 77: EP Recording System Installed Base, by Country, Europe, 2010 -
2016
- Table 78: Remote Steering System Installed Base, by Country, Europe, 2010
- 2016
- Table 79: RF Ablation Generator Installed Base, by Country, Europe, 2010 -
2016
- Table 80: EP Lab System Market, by Country, Europe (US$, € , and
£), 2010 - 2016
- Table 81: EP Lab System Market, by Product Type, Europe (US$ and € ),
2010 - 2016
- Table 82: X-Ray System Market, by Country, Europe (US$), 2010 - 2016
- Table 83: X-Ray System Market, by Country, Europe (€ and £),
2010 - 2016
- Table 84: X-Ray System Market Growth, by Country, Europe, 2011 - 2016
- Table 85: X-Ray System Market, by Country, as a % of Total, Europe, 2010 -
2016
- Table 86: EP Recording System Market, by Country, Europe (US$), 2010 - 2016
- Table 87: EP Recording System Market, by Country, Europe (€ and
£), 2010 - 2016
- Table 88: EP Recording System Market Growth, by Country, Europe, 2011 -
2016
- Table 89: EP Recording System Market, by Country, as a % of Total, Europe,
2010 - 2016
- Table 90: Remote Steering System Market, by Country, Europe (US$), 2010 -
2016
- Table 91: Remote Steering System Market, by Country, Europe (€ and
£), 2010 - 2016
- Table 92: Remote Steering System Market Growth, by Country, Europe, 2011 -
2016
- Table 93: Remote Steering System Market, by Country, as a % of Total,
Europe, 2010 - 2016
- Table 94: RF Ablation Generator Units, by Country, Europe, 2010-2016
- Figure 5: EP Diagnostic Catheter Units, by Product Feature, Europe, 2010 -
2016
- Table 95: EP Diagnostic Catheter Procedures, by Country, Europe, 2010 -
2016
- Table 96: EP Diagnostic Catheter Procedures, by Procedure Type, Europe,
2010 - 2016
- Table 97: EP Diagnostic Catheter Market, by Country, Europe (US$, € ,
and £), 2010 - 2016
- Table 98: EP Diagnostic Catheter Market, by Product Type, Europe (US$ and
€ ), 2010 - 2016
- Table 99: EP Diagnostic Catheter Reprocessing, by Product Feature,
Germany, 2010 - 2016
- Table 100: EP Conventional Diagnostic Catheter Market, by Country, Europe
(US$, € , and £), 2010 - 2016
- Table 101: Conventional Diagnostic Catheter Market, by Product Feature,
Europe (US$ and € ), 2010 - 2016
- Table 102: Conventional Fixed Diagnostic Catheter Market, by Country,
Europe (US$), 2010 - 2016
- Table 103: Conventional Fixed Diagnostic Catheter Market, by Country,
Europe (€ and £), 2010 - 2016
- Table 104: Conventional Fixed Diagnostic Catheter Market Growth, by
Country, Europe, 2011 - 2016
- Table 105: Conventional Fixed Diagnostic Catheter Market, by Country, as a
% of Total, Europe, 2010 - 2016
- Table 106: Conventional Steerable Diagnostic Catheter Market, by Country,
Europe (US$), 2010 - 2016
- Table 107: Conventional Steerable Diagnostic Catheter Market, by Country,
Europe (€ and £), 2010 - 2016
- Table 108: Conventional Steerable Diagnostic Catheter Market Growth, by
Country, Europe, 2011 - 2016
- Table 109: Conventional Steerable Diagnostic Catheter Market, by Country,
as a % of Total, Europe, 2010 - 2016
- Table 110: Advanced Diagnostic Catheter Market, by Country, Europe (US$,
€ , and £), 2010 - 2016
- Table 111: Advanced Diagnostic Catheter Market, by Product Feature, Europe
(US$ and € ), 2010 - 2016
- Table 112: Advanced Loop Diagnostic Catheter Market, by Country, Europe
(US$), 2010 - 2016
- Table 113: Advanced Loop Diagnostic Catheter Market, by Country, Europe
(€ and £), 2010 - 2016
- Table 114: Advanced Loop Diagnostic Catheter Market Growth, by Country,
Europe, 2011 - 2016
- Table 115: Advanced Loop Diagnostic Catheter Market, by Country, as a % of
Total, Europe, 2010 - 2016
- Table 116: Advanced Other Diagnostic Catheter Market, by Country, Europe
(US$), 2010 - 2016
- Table 117: Advanced Other Diagnostic Catheter Market, by Country, Europe
(€ and £), 2010 - 2016
- Table 118: Advanced Other Diagnostic Catheter Market Growth, by Country,
Europe, 2011 - 2016
- Table 119: Advanced Other Diagnostic Catheter Market, by Country, as a %
of Total, Europe, 2010 - 2016
- Figure 6: EP Ablation Catheter Market, by Product Feature, Europe (US$),
2010 - 2016
- Table 120: EP Ablation Catheter Procedures, by Indication, Europe, 2010 -
2016
- Table 121: EP Ablation Catheter Procedures, by Country, Europe, 2010 - 2016
- Table 122: EP Ablation Catheter Procedures, by Product Type, Europe, 2010
- 2016
- Table 123: RF Ablation Catheter Procedures, by Country, Europe, 2010 - 2016
- Table 124: RF Ablation Catheter Procedures, by Product Feature, Europe,
2010 - 2016
- Table 125: Cryoablation Catheter Procedures, by Country, Europe, 2010 -
2016
- Table 126: Navigational Ablation Procedures, by Country, Europe, 2010 -
2016
- Table 127: Navigational Ablation Procedures, by Procedure Type, Europe,
2010 - 2016
- Table 128: EP Ablation Catheter Market, by Country, Europe (US$, € ,
and £), 2010 - 2016
- Table 129: EP Ablation Catheter Market, by Product Type, Europe (US$ and
€ ), 2010 - 2016
- Table 130: RF Ablation Catheter Reprocessing, by Product Feature, Germany,
2010 - 2016
- Table 131: RF Ablation Catheter Market, by Country, Europe (US$, € ,
and £), 2010 - 2016
- Table 132: RF Ablation Catheter Market, by Product Feature, Europe (US$
and € ), 2010 - 2016
- Table 133: RF Conventional Ablation Catheter Market, by Country, Europe
(US$), 2010 - 2016
- Table 134: RF Conventional Ablation Catheter Market, by Country, Europe
(€ and £), 2010 - 2016
- Table 135: RF Conventional Ablation Catheter Market Growth, by Country,
Europe, 2011 - 2016
- Table 136: RF Conventional Ablation Catheter Market, by Country, as a % of
Total, Europe, 2010 - 2016
- Table 137: RF Irrigated-Tip Ablation Catheter Market, by Country, Europe
(US$), 2010 - 2016
- Table 138: RF Irrigated-Tip Ablation Catheter Market, by Country, Europe
(€ and £), 2010 - 2016
- Table 139: RF Irrigated-Tip Ablation Catheter Market Growth, by Country,
Europe, 2011 - 2016
- Table 140: RF Irrigated-Tip Ablation Catheter Market, by Country, as a %
of Total, Europe, 2010 - 2016
- Table 141: RF Specialty Ablation Catheter Market, by Country, Europe
(US$), 2010 - 2016
- Table 142: RF Specialty Ablation Catheter Market, by Country, Europe
(€ and £), 2010 - 2016
- Table 143: RF Specialty Ablation Catheter Market Growth, by Country,
Europe, 2011 - 2016
- Table 144: RF Specialty Ablation Catheter Market, by Country, as a % of
Total, Europe, 2010 - 2016
- Table 145: Cryoablation Catheter Market, by Country, Europe (US$), 2010 -
2016
- Table 146: Cryoablation Catheter Market, by Country, Europe (€ and
£), 2010 - 2016
- Table 147: Cryoablation Catheter Market Growth, by Country, Europe, 2011 -
2016
- Table 148: Cryoablation Catheter Market, by Country, as a % of Total,
Europe, 2010 - 2016
- Table 149: Navigational Accessory Market, by Country, Europe (US$), 2010 -
2016
- Table 150: Navigational Accessory Market, by Country, Europe (€ and
£), 2010 - 2016
- Table 151: Navigational Accessory Market Growth, by Country, Europe, 2011
- 2016
- Table 152: Navigational Accessory Market, by Country, as a % of Total,
Europe, 2010 - 2016
APPENDIX A: METHODOLOGY
- Table 153: Average Currency Exchange Rates, 2011
APPENDIX B: MRG ACRONYMS AND INITIALISMS
- MRG Acronyms and Initialisms
APPENDIX C: BIBLIOGRAPHY
|
